Cost Effectiveness of Ibutilide With Prophylactic Magnesium in the Treatment of Atrial Fibrillation

Author： Craig I. Coleman   James S. Kalus   C. Michael White   Anne P. Spencer  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.13, 2004-01, pp. : 877-883

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Therapies for Atrial Fibrillation: A Review

By Teng M.P.  

PharmacoEconomics, Vol. 18, Iss. 4, 2000-10 ,pp. : 317-333

Adis International

Access to resources Recommend Favorite

Ximelagatran Cost Effectiveness for Stroke Prevention in Atrial Fibrillation

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 4, 2005-12 ,pp. : 279-283

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ibutilide plus magnesium cost effective for AF

By  

Inpharma, Vol. 1, Iss. 1452, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Ibutilide plus magnesium cost effective for AF

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 460, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation

By Verhoef Talitha I   Redekop William K   Veenstra David L   Thariani Rahber   Beltman Peter A   van Schie Rianne MF   de Boer Anthonius   Maitland-van der Zee Anke-Hilse  

Pharmacogenomics, Vol. 14, Iss. 8, 2013-06 ,pp. : 869-883

Future Medicine

Access to resources Recommend Favorite